Investment
Global Capital Network
Building the Global Platform Connecting China’s Healthcare Innovation Ecosystem
To become the world’s leading platform connecting China’s healthcare innovation ecosystem with global opportunities.
We aim to build an open, trusted, and international healthcare innovation ecosystem where global capital, industry resources, technologies, and talent connect efficiently to accelerate the global impact of healthcare innovation.
Opportunities
Medical investment opportunities refer to high-quality industrial investment targets and cooperative opportunities with compliance, growth and implementation potential in the big health B2B track, deeply covering segmented fields such as medical devices, biomedicine, in vitro diagnosis, smart healthcare, medical consumables, medical supply chains, medical beauty and health care, and third-party medical services. Relying on medical industry resources and industrial data, the platform accurately screens high-quality medical projects and enterprise resources with qualification advantages, technological innovation advantages, market rigid demand and policy support, including diversified opportunities such as start-up technology incubation, growth enterprise expansion, mature industrial integration and cross-border medical cooperation. It provides accurate, compliant and high-value industrial investment docking opportunities for upstream and downstream medical B2B enterprises, industrial investors and medical parks, helping all parties seize the development dividends of segmented medical tracks.
Licensing
Licensing in the medical field is the core compliance guarantee for medical B2B investment and project operation. It provides full-chain compliant authorization and qualification licensing supporting services for scenarios such as medical industrial investment, project cooperation, product launch and enterprise M&A. The core scope includes medical device registration certificates, production licenses, business licenses, medical device intellectual property (patent, technical copyright) authorization, pharmaceutical enterprise production and operation qualifications, medical platform filing permits, cross-border medical product access authorization and special industry compliance filings.
M&A
Licensing in the medical field is the core compliance guarantee for medical B2B investment and project operation. It provides full-chain compliant authorization and qualification licensing supporting services for scenarios such as medical industrial investment, project cooperation, product launch and enterprise M&A. The core scope includes medical device registration certificates, production licenses, business licenses, medical device intellectual property (patent, technical copyright) authorization, pharmaceutical enterprise production and operation qualifications, medical platform filing permits, cross-border medical product access authorization and special industry compliance filings.
Opportunities
Medical investment opportunities refer to high-quality industrial investment targets and cooperative opportunities with compliance, growth and implementation potential in the big health B2B track, deeply covering segmented fields such as medical devices, biomedicine, in vitro diagnosis, smart healthcare, medical consumables, medical supply chains, medical beauty and health care, and third-party medical services. Relying on medical industry resources and industrial data, the platform accurately screens high-quality medical projects and enterprise resources with qualification advantages, technological innovation advantages, market rigid demand and policy support, including diversified opportunities such as start-up technology incubation, growth enterprise expansion, mature industrial integration and cross-border medical cooperation. It provides accurate, compliant and high-value industrial investment docking opportunities for upstream and downstream medical B2B enterprises, industrial investors and medical parks, helping all parties seize the development dividends of segmented medical tracks.
Reports
The reports deeply analyze the industrial scale, localization process, market access rules, upstream and downstream industrial chain structure and future development trends of each track, accurately tapping investment dividends and development opportunities in segmented tracks, and providing authoritative and comprehensive industry data and trend references for medical enterprise strategic layout, industrial investor track selection and medical park investment planning.
Medical Industry Track Research Report
Focusing on core segmented B2B tracks of the big health industry such as medical devices, biomedicine, in vitro diagnosis, smart healthcare and medical consumables, we deliver systematic and panoramic industry research reports based on national medical policies, industry supervision dynamics, market supply and demand patterns and technological iteration trends.
Medical Project Investment & Financing Analysis Report
Tailored for medical B2B investment, financing and M&A cooperation scenarios, we issue special project investment and financing analysis reports for individual medical technology enterprises, innovative pharmaceutical companies, medical device R&D projects, smart medical platforms and other entities.
Medical Industry Risk & Compliance Evaluation Report
In combination with the strong supervision characteristics of the medical industry, we issue professional risk and compliance evaluation reports for full business scenarios including medical investment, M&A, financing, product launch and cross-border cooperation.
Due Diligence
Medical due diligence is the core compliance and risk control process before the implementation of medical B2B investment, M&A and financing. It carries out full-dimensional special due verification for special medical projects and enterprises such as medical devices, biomedicine and medical services.
It conducts in-depth professional financial and legal due diligence targeting the core risk points of investment, financing and M&A transactions of medical enterprises. In terms of finance, it focuses on verifying the enterprise’s revenue structure, R&D investment, cost accounting, cash flow status, assets and liabilities, tax compliance, subsidy income and investment and financing history, identifying problems such as financial fraud, inflated revenue, hidden liabilities and tax risks. In terms of legal affairs, it focuses on the enterprise’s equity structure, ownership clarity, industrial and commercial filing information, judicial litigation, arbitration disputes, administrative penalties, contract breaches and external guarantees, comprehensively sorting out potential legal risks and equity defects of target enterprises, and providing rigorous data and legal basis for transaction valuation, equity design and risk hedging.